Researchers from the Icahn School of Medicine at Mount Sinai in New York have discovered a novel approach to protecting insulin-producing beta cells from the damaging effects of glucolipotoxicity-a harmful condition linked to the progression of type 2 diabetes (T2D).
Novel strategy targets beta cell dysfunction in type 2 diabetes
- Post author:admin
- Post published:March 4, 2025
- Post category:uncategorized